CureTech Ltd.
11Patents
8Active
11Granted
42Portfolio score
Filing activity: Apr 9, 2004 → Nov 7, 2014 · 4 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7332582B2 | Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency | Chemistry; Metallurgy | 78 | Expired |
| US8686119B2 | Variants of humanized immunomodulatory monoclonal antibodies | Chemistry; Metallurgy | 41 | Active |
| US7524498B2 | Human immunomodulatory monoclonal antibodies for the treatment of cancer | Chemistry; Metallurgy | 33 | Active |
| US7122372B2 | Peptide useful in immunomodulation | Chemistry; Metallurgy | 27 | Expired |
| US8747847B2 | Monoclonal antibodies for tumor treatment | Chemistry; Metallurgy | 26 | Active |
| US7981416B2 | Humanized immunomodulatory monoclonal antibodies for the treatment of immunodeficiency | Chemistry; Metallurgy | 25 | Active |
| US7329639B2 | Peptide useful in immunomodulation | Chemistry; Metallurgy | 25 | Expired |
| US9580504B1 | Pidilizumab monoclonal antibody therapy following stem cell transplantation | Chemistry; Metallurgy | 7 | Active |
| US9416175B2 | Variants of humanized immunomodulatory monoclonal antibodies | Chemistry; Metallurgy | 3 | Active |
| US9309308B2 | Monoclonal antibodies for tumor treatment | Chemistry; Metallurgy | 3 | Active |
| US7745397B2 | Peptide useful in immunomodulation | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.